ENHERTU shows 92% invasive disease-free survival rate at three years in breast cancer trial

A new drug for pancreatic cancer has demonstrated a promising 41% response rate in recent clinical trials, offering hope to patients battling this aggressive disease. This significant finding could lead to more effective treatment options and improve survival rates, making it a crucial development in cancer research.

Kelun-Biotech has announced promising results from its phase 3 clinical trial for a new breast cancer drug, which could significantly improve treatment options for patients. This development is crucial as it highlights advancements in cancer therapies, potentially leading to better outcomes and quality of life for those affected by the disease.

At the ESMO 2025 conference, the drug Enhertu has demonstrated the highest pathologic complete response (pCR) rate in patients with HER2-positive early breast cancer. This is significant as it highlights a promising advancement in treatment options for a challenging subtype of breast cancer, potentially improving outcomes for many patients.

Gedatolisib has demonstrated promising results in a recent breast cancer trial, showcasing its potential to improve treatment outcomes for patients. This development is significant as it offers hope for more effective therapies in a field that continually seeks advancements. With ongoing research, gedatolisib could become a vital option for those battling this challenging disease.

Exelixis has announced that its drug cabozantinib significantly reduces the risk of progression in lung and thymic neuroendocrine tumors (NET) by an impressive 81%. This breakthrough is crucial as it offers new hope for patients battling these challenging cancers, potentially improving their quality of life and survival rates. The findings from the clinical trial highlight the importance of innovative treatments in oncology, paving the way for further research and development in cancer therapies.

Junshi Biosciences has received FDA approval to initiate a clinical trial for a new lung cancer treatment, marking a significant step forward in the fight against this prevalent disease. This approval not only highlights the company's innovative approach in biotechnology but also brings hope to patients seeking new options in their battle against lung cancer.

AB Science has announced encouraging results from its phase 1 clinical trial for a new leukemia treatment. This development is significant as it offers hope for patients battling this challenging disease, potentially leading to more effective therapies in the future. The positive data could pave the way for further research and investment in innovative cancer treatments.

AstraZeneca has received an unusual sell rating from Deutsche Bank, raising concerns about its drug pipeline, especially regarding breast cancer treatments. This downgrade is significant as it reflects growing skepticism among analysts about the company's future prospects, which could impact investor confidence and the stock's performance.

The Louvre Museum in Paris was forced to close after a daring heist at the Galerie d’Apollon, where thieves made off with valuable historical jewels from the royal collection. This incident not only disrupts the museum's operations but also raises concerns about security in one of the world's most famous cultural institutions. The theft highlights the ongoing challenges museums face in protecting their priceless artifacts, making it a significant event for art lovers and historians alike.

The UK government has pledged to create 400,000 jobs in the clean energy sector, a move that Ed Miliband emphasizes is crucial for reducing energy bills sustainably. This initiative not only aims to boost employment but also addresses the pressing need for a greener economy, making it a significant step towards energy independence and environmental responsibility.

Walmart has launched a stylish and portable record player and Bluetooth speaker combo for just $42, which has received rave reviews for its fantastic sound quality and attractive design. This product is significant as it caters to the growing trend of vinyl enthusiasts and those looking for affordable yet high-quality audio solutions.

ICICI Bank's recent ADR earnings report has disappointed investors, as both earnings and revenue fell short of expectations. This news is significant because it reflects challenges the bank may be facing in a competitive market, potentially impacting investor confidence and future growth prospects.

HDFC Bank's recent ADR earnings report has disappointed investors, as the bank's revenue fell short of expectations. This news is significant because it reflects the bank's current financial health and could impact investor confidence and stock performance moving forward.

The ongoing US-China trade war is casting a shadow over the global economic outlook, as both nations continue to impose tariffs and trade restrictions. This situation is being referred to as the 'new normal,' indicating that businesses and economies worldwide may need to adapt to a prolonged period of uncertainty. The implications of this trade conflict are significant, affecting supply chains, market stability, and international relations, making it crucial for stakeholders to navigate these challenges carefully.